|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 66.37 USD | +0.97% |
|
+0.06% | -14.66% |
| 12-16 | Leerink Partners Adjusts Price Target on DexCom to $92 From $81, Maintains Outperform Rating | MT |
| 12-11 | Citigroup Adjusts DexCom Price Target to $77 From $75, Maintains Buy Rating | MT |
| Capitalization | 25.89B 21.98B 20.57B 19.28B 35.58B 2,353B 39B 240B 92.69B 1,106B 97.09B 95.07B 4,007B | P/E ratio 2025 * |
32.1x | P/E ratio 2026 * | 27.4x |
|---|---|---|---|---|---|
| Enterprise value | 26.06B 22.13B 20.7B 19.41B 35.82B 2,369B 39.26B 242B 93.31B 1,113B 97.74B 95.71B 4,034B | EV / Sales 2025 * |
5.61x | EV / Sales 2026 * | 4.89x |
| Free-Float |
95.22% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: DexCom, Inc.
| 1 day | +0.97% | ||
| 1 week | +0.06% | ||
| Current month | +4.57% | ||
| 1 month | +14.31% | ||
| 3 months | -13.30% | ||
| 6 months | -20.04% | ||
| Current year | -14.66% |
| 1 week | 65.2 | 69.77 | |
| 1 month | 58.14 | 69.77 | |
| Current year | 54.11 | 93.25 | |
| 1 year | 54.11 | 93.25 | |
| 3 years | 54.11 | 142 | |
| 5 years | 54.11 | 164.86 | |
| 10 years | 10.66 | 164.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jacob Leach
CEO | Chief Executive Officer | 46 | 2025-09-13 |
Jereme Sylvain
DFI | Director of Finance/CFO | 45 | 2021-03-18 |
| Chief Tech/Sci/R&D Officer | 48 | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Nick Augustinos
BRD | Director/Board Member | 66 | 2009-11-19 |
Steven Altman
BRD | Director/Board Member | 63 | 2013-11-06 |
Mark Foletta
CHM | Chairman | 65 | 2025-09-13 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.97% | +0.06% | -13.14% | -42.10% | 25.64B | ||
| -1.25% | +4.63% | +12.64% | +18.66% | 223B | ||
| -0.86% | -1.91% | +20.12% | +27.37% | 126B | ||
| -2.45% | +1.31% | +48.69% | +104.88% | 67.96B | ||
| -1.85% | +4.01% | -13.70% | -21.29% | 57.11B | ||
| -1.12% | +0.04% | +17.95% | +74.71% | 52.41B | ||
| -0.41% | -1.65% | +19.90% | +38.25% | 24.94B | ||
| +0.48% | +0.10% | +8.69% | -31.46% | 23.72B | ||
| -0.24% | -1.01% | -24.51% | +18.80% | 21.76B | ||
| -0.95% | -1.86% | +8.75% | -3.43% | 20.51B | ||
| Average | -0.76% | +0.19% | +8.54% | +18.44% | 64.38B | |
| Weighted average by Cap. | -1.11% | +1.54% | +13.74% | +26.28% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 4.64B 3.94B 3.69B 3.46B 6.38B 422B 7B 43.1B 16.63B 198B 17.42B 17.06B 719B | 5.23B 4.44B 4.16B 3.9B 7.19B 476B 7.88B 48.55B 18.73B 223B 19.62B 19.21B 810B |
| Net income | 831M 706M 660M 619M 1.14B 75.57B 1.25B 7.71B 2.98B 35.5B 3.12B 3.05B 129B | 989M 840M 786M 737M 1.36B 89.95B 1.49B 9.18B 3.54B 42.26B 3.71B 3.63B 153B |
| Net Debt | 174M 148M 139M 130M 240M 15.85B 263M 1.62B 624M 7.45B 654M 640M 26.99B | -322M -274M -256M -240M -443M -29.3B -486M -2.99B -1.15B -13.77B -1.21B -1.18B -49.9B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-16 | 66.37 $ | +0.97% | 4,591,463 |
| 25-12-15 | 65.73 $ | -1.84% | 7,428,659 |
| 25-12-12 | 66.96 $ | -2.87% | 6,833,025 |
| 25-12-11 | 68.94 $ | +2.04% | 6,926,610 |
| 25-12-10 | 67.56 $ | +1.85% | 8,527,643 |
Delayed Quote Nasdaq, December 16, 2025 at 04:00 pm
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DXCM Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















